NMC Royal Khalifa City: A lifeline for women facing placenta accreta spectrum disorder
The highly specialised PASD team at NMC is transforming the standard approach by offering innovative, patient-centered solutions that prioritise both safety and fertility preservation
In June 2023, NMC Royal Hospital, Khalifa City, proudly launched its Placenta Accreta Spectrum Disorder (PASD) programme - a groundbreaking initiative designed to provide world-class care for expectant mothers diagnosed with this high-risk condition. Over the past year, ten women have successfully undergone treatment through this programme, each receiving expert, multidisciplinary care tailored to their unique medical needs.
For women diagnosed with PASD, the journey can be emotionally and physically challenging due to the potential complications involved. PASD occurs when the placenta attaches too deeply into the uterine wall, posing serious risks during childbirth, including severe bleeding and, in many cases, the need for a hysterectomy. At NMC Royal Hospital, Khalifa City, our highly specialised PASD team is transforming the standard approach by offering innovative, patient-centered solutions that prioritise both safety and fertility preservation.
What distinguishes our PASD programme is its personalised and meticulously coordinated treatment protocol. Each patient undergoes a comprehensive evaluation, including MRI confirmation, allowing for detailed pre-operative planning. This ensures every expectant mother receives an individualised care plan specifically tailored to her condition. Our multidisciplinary team collaborates on every PASD case and comprises obstetricians, maternal-fetal medicine specialists, interventional radiologists, urologists, anesthesiologists, intensive care experts, and a highly skilled surgical team.
While hysterectomy is often the standard course of action in many hospitals to manage PASD and prevent life-threatening complications, our advanced PASD protocols, state-of-the-art facilities, and experienced team have changed the narrative. Remarkably, none of the women treated under our PASD programme have required a hysterectomy. Moreover, blood loss was kept to a minimum in all cases, leading to faster recovery times and significantly improved long-term maternal health outcomes. This represents a major breakthrough in PASD treatment - offering women not only hope but also the possibility of preserving their fertility while ensuring the safest possible delivery.
Placenta Accreta Spectrum Disorder is one of the most complex pregnancy-related conditions, and its successful management demands expertise, experience, and a highly integrated team approach tailored to each individual case. Early diagnosis, coupled with meticulous planning, plays a pivotal role in ensuring safer deliveries and better maternal outcomes.
At NMC Royal Hospital, Khalifa City, we are proud to lead the way in PASD care. We remain steadfast in our commitment to driving innovation, setting new benchmarks in women's health, and providing every woman facing this condition with not only the highest level of medical expertise but also the compassion, reassurance, and support she deserves.
Our dedication to continuous advancement and excellence in maternal-fetal care ensures that every expectant mother who walks through our doors receives the safest, most effective, and most compassionate treatment available today.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
02-06-2025
- Al Etihad
Pulse and hopes high when healthcare and Al hold hands
3 June 2025 01:00 EISSA ALI ALMANNEI *Technological progress sometimes affects human lives slightly and sometimes in profound ways. But when it empowers vital sectors like healthcare, the hopes pinned on this technological revolution increase. This is exactly the case with harnessing artificial intelligence in the healthcare industry and the adoption of AI tools by healthcare institutions to assist at every stage of the care language models, chatbots, and voice assistants are now integrated into AI-powered workflows across clinics and hospitals, helping in internal processes and medical records. AI can improve operations, from human resources to insurance claims, facilitating data management and applying AI tools to generate automated reports and resource utilisation metrics in real saves a lot of time on administrative tasks and interactions while reducing costs. AI is not limited to administrative and financial operations. In fact, it can give anonymous patient data, such as MRI scans, CT images, lab results, and clinical notes, to feed AI diagnostic radiology, AI helps doctors transcend the limitations of the human eye, as it trains algorithms to reconstruct blurry images and highlight areas of concern, such as tumors or fractures. With big data and patient record analysis, healthcare professionals can detect patterns and risk factors that might be missed in traditional diagnostic of the fundamental advantages of AI in healthcare is its ability to improve diagnostic accuracy and treatment plans, which enables faster decision-making by providing physicians with precise, real-time information. In emergencies, where time is critical to saving lives, AI-assisted robotics can improve surgical outcomes, aid surgeons in enhancing precision, reduce complications, and improve patient the pharmaceutical sector, companies rely on AI to analyse chemical composition databases, protein interactions, and side effects. This not only accelerates drug development but also increases the success rate of new medications while improving safety and reducing the risk of adverse reactions. AI can even predict individual responses to treatments by analysing genetic profiles and medical histories and discovering how a specific gene variant affects drug addition, AI can simulate patients in clinical training, allowing students to adapt to various cases. Virtual patients respond in real time to what the student says or does, creating a more realistic experience. AI is also being used in mental health, guiding cancer survivors through post-treatment care, and assisting in the early detection of diseases, including certain types of AI is still relatively new in healthcare, there is now a smart hospital in China operated by fourteen AI-powered virtual doctors who diagnose and treat patients without any human staff. This virtual team is capable of treating over 3,000 patients daily. This implies that AI's ability to match, or even exceed, human diagnostic capabilities in terms of accuracy and speed is within there are challenges related to the ambiguity of AI models to physicians, making it difficult to understand how they arrive at conclusions. This lack of clarity can confuse doctors when they cannot grasp the reasons behind an algorithm's there are concerns about protecting patients' medical privacy, as AI relies on massive datasets that frequently contain sensitive health information. AI outcomes can also be biased due to disparities or differences in training data, leading to distorted results. Therefore, the quality and balance of the data used to train these models are critical to ensuring accurate and reliable hopes for AI in healthcare are undeniable. Medical AI systems can process information faster than any human doctor, but caution is needed to address challenges, use data analysis and advanced analytics, and continue developing technologies that aid in disease diagnosis, prevention, personalised treatment, and drug development to improve the quality of human life. * The writer is a researcher at TRENDS Research & Advisory
Gulf Today
16-05-2025
- Gulf Today
NMC Specialty Hospital Abu Dhabi restores hope to Achalasia patients in UAE through minimally invasive and highly specialized Peroral Endoscopic Myotomy (POEM) procedure
In a major advancement for gastrointestinal care in the region, NMC Specialty Hospital, Abu Dhabi, has successfully performed a cutting-edge procedure to treat achalasia, a rare and progressive swallowing disorder using a minimally invasive endoscopic procedure known as POEM (Peroral Endoscopic Myotomy). The patient, a 23-year-old nurse, had been battling severe achalasia symptoms for several years. By the time she was referred to Dr. Yogesh Shastri, Consultant and Head of the Department of Gastroenterology at NMC Specialty Hospital, her condition had significantly deteriorated. She was unable to eat or drink without extreme discomfort, had become severely malnourished and was relying on intravenous fluids. She also suffered from recurrent chest infections and experienced drastic weight loss, which had forced her to take indefinite leave from work. Achalasia, which affects approximately 1 in 100,000 people, occurs when the lower esophageal sphincter (LES) fails to relax, preventing food and liquids from entering the stomach. Over time, this leads to food accumulation in the esophagus resulting in regurgitation, malnutrition, chest pain and recurrent respiratory infections. If left untreated, the disorder can severely impact overall health and quality of life. Given the severity and complexity of her case, Dr. Shastri and his team opted for POEM - a scarless, natural orifice procedure performed entirely through the mouth without any skin incisions. The technique involves creating a narrow and long tunnel within the esophageal wall to precisely cut the tight or malfunctioning muscle to relieve the obstruction at the junction of food pipe and stomach. The procedure, known for its high success rate and faster recovery time, is considered a significant advancement compared to traditional and conventional surgical approaches. 'POEM is especially beneficial and is standard of care in cases like this one, where other treatments such as balloon dilation or Botox injections are no longer viable,' said Dr. Shastri. 'It allows for a tailored and precise muscle incision depending on the severity of the disease and provides long-lasting relief with minimal risk'. The outcome of the endoscopic surgery was highly successful, and the patient's transformation was immediate. Within days of the procedure, she was able to eat and drink normally for the first time in months. Her strength and energy levels improved, she began regaining weight, and has since resumed her professional duties with renewed energy and optimism. 'After everything I've been through, being able to drink water without fear and discomfort felt like being reborn,' said the patient. 'As a nurse, I understood the risks, but I also knew this was my only chance to reclaim my life. I'm beyond grateful to Dr. Shastri and the team at NMC.' Reflecting on her journey, she added: 'When I was at my lowest, even a sip of water felt impossible. Today, I can enjoy meals, socialize again, and return to doing what I love - caring for others - with a deeper compassion having experienced firsthand what it means to suffer. It feels like I've been given my life back.' POEM remains a highly specialized procedure available only in select centers globally, requiring specialised training and advanced equipment. By offering the procedure locally, NMC Specialty Hospital is bridging a critical gap in care for achalasia patients across the UAE and the wider region and for patients who previously had to travel to countries like the US, Germany, India or South Korea. 'At NMC Specialty Hospital, Abu Dhabi our focus is not just on treating disease, but restoring dignity and quality of life,' added Dr. Shastri. 'Innovations like POEM are at the heart of our mission to deliver world-class, patient centered care using the latest medical advancements'. This successful case underscores NMC Healthcare's commitment to excellence in clinical care and innovation. As the hospital continues to invest in advanced procedures and multidisciplinary expertise, it offers renewed hope to patients facing rare and challenging conditions here in the UAE.
Al Etihad
14-05-2025
- Al Etihad
New Thalassemia and Sickle Cell Centre opened at Burjeel Medical City in Abu Dhabi
14 May 2025 22:26 ABU DHABI (ALETIHAD)Burjeel Holdings has launched a Thalassemia and Sickle Cell Centre at Burjeel Medical City (BMC) in Abu Dhabi, marking a significant step towards redefining the standard of care for individuals with inherited blood launch took place under the patronage and in the presence of Sheikha Shaikha bint Saif bin Mohamed Al Nahyan, wife of Sheikh Dr. Sultan bin Khalifa Al Nahyan, Advisor to His Highness the President and Chairperson of the Emirates Thalassemia her opening speech on the occasion, Sheikha Shamma said, "In my mother's unwavering commitment to thalassemia patients, I have witnessed how compassion, when paired with vision and persistence, can transform countless lives across generations and beyond borders."The newly inaugurated Thalassemia and Sickle Cell Centre by Burjeel Holdings' state-of-the-art facility will provide compassionate and comprehensive care to patients and their families," she centre was inaugurated in a grand ceremony also attended by Sheikh Khalifa bin Sultan bin Khalifa Al Nahyan, Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, Omran Al Khoori, Board Member, and a number of Burjeel opening was also attended by members of the Board of Directors of the Emirates Thalassemia Society, and a number of leaders from the Department of Health in Abu centre supports individuals living with thalassemia and sickle cell disease by delivering a holistic, patient-centric, and evidence-based model of care, supported by a multidisciplinary team of world-renowned experts. The centre offers fully integrated outpatient services and a dedicated transfusion unit operating seven days a week. The centre is distinguished by several key differentiators, including extended transfusion services across the UAE via Burjeel's hospital network, internationally validated MRI quantification of iron overload in the heart and liver, and in-house molecular genotyping capabilities. Prof. Khaled Musallam, Group Chief Research Officer of Burjeel Holdings and Director of the Thalassemia and Sickle Cell Centre, said, "What makes this centre unique is the combination of global clinical expertise, access to the latest therapies, and the ability to deliver care in line with international guidelines authored by the very people leading the services here."With an international advisory board of global key opinion leaders, the centre adheres to leading global standards, including those of the Thalassaemia International Federation, with necessary local adaptations to meet patients' centre will also work closely with the Centre for Research on Rare Blood Disorders (CR-RBD) at BMC, also headed by Prof. Khaled Musallam, to identify and enroll eligible patients in global clinical trials, ensuring access to the latest innovations in treatment, including disease-modifying and curative has swiftly become recognised as one of the most active hubs for research on haheemoglobin disorders globally. Source: Aletihad - Abu Dhabi
